• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE BD ULTRA-FINE¿ INSULIN SYRINGE WITH STERILE INTERIOR; HYPODERMIC SINGLE LUMEN NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE BD ULTRA-FINE¿ INSULIN SYRINGE WITH STERILE INTERIOR; HYPODERMIC SINGLE LUMEN NEEDLE Back to Search Results
Catalog Number 324903
Device Problem Contamination of Device Ingredient or Reagent (2901)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/10/2023
Event Type  malfunction  
Event Description
It was reported that the bd ultra-fine¿ insulin syringe with sterile interior experienced foreign matter in fluid path.The following information was provided by the initial reporter: the customer stated that after injecting the drug into the syringe, the customer found a orange fm on the inner wall of the syringe.
 
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
H6: investigation summary customer returned (1) loose 1cc, 6mm syringe without any packaging.Customer states that they found an orange fm on the inner wall of the syringe.The syringe was returned with approximately 40 units of a clear liquid inside the barrel.The sample was visually examined and exhibited a loose, orange piece of material floating in the clear liquid in the barrel.The liquid was subsequently removed from the barrel.The orange piece of material was also removed from the barrel.This piece was measured with a ruler and found to be slightly longer than 2 mm and about 0.5 mm wide.This material was prepared for ftir spectral analysis by flattening the material.The ftir spectral analysis shows that this material is most likely polyethylene mixed with some silicone.A review of the device history record was completed for batch# 2199495.All inspections were performed per the applicable operations qc specifications.Embecta was able to duplicate or confirm the customer¿s indicated failure.
 
Event Description
It was reported that the bd ultra-fine¿ insulin syringe with sterile interior experienced foreign matter in fluid path.The following information was provided by the initial reporter: the customer stated that after injecting the drug into the syringe, the customer found a orange fm on the inner wall of the syringe.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ULTRA-FINE¿ INSULIN SYRINGE WITH STERILE INTERIOR
Type of Device
HYPODERMIC SINGLE LUMEN NEEDLE
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
Manufacturer (Section G)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key16502860
MDR Text Key310961180
Report Number1920898-2023-00100
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number324903
Device Lot Number2199495
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/22/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/10/2023
Initial Date FDA Received03/08/2023
Supplement Dates Manufacturer Received03/09/2023
Supplement Dates FDA Received03/22/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-